 | Up a level |
Christgen, Matthias, Bartels, Stephan 
ORCID: 0000-0002-8903-2345, Radner, Martin, Raap, Mieke, Rieger, Luisa, Christgen, Henriette, Gluz, Oleg, Nitz, Ulrike, Harbeck, Nadia, Lehmann, Ulrich and Kreipe, Hans
(2019).
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profiling.
Gene Chromosomes Cancer, 58 (3).
S. 175 - 186.
HOBOKEN:
WILEY.
ISSN 1098-2264
Grote, Isabel ORCID: 0000-0002-6731-187X, Bartels, Stephan ORCID: 0000-0002-8903-2345, Christgen, Henriette, Radner, Martin, Gronewold, Malte, Kandt, Leonie, Raap, Mieke ORCID: 0000-0001-8338-6209, Lehmann, Ulrich ORCID: 0000-0003-2350-6584, Gluz, Oleg, Graeser, Monika, Kuemmel, Sherko, Nitz, Ulrike, Harbeck, Nadia, Kreipe, Hans and Christgen, Matthias
(2022).
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer.
Mod. Pathol., 35 (12).
S. 1804 - 1812.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1530-0285
Grote, Isabel ORCID: 0000-0002-6731-187X, Bartels, Stephan, Kandt, Leonie, Bollmann, Laura, Christgen, Henriette, Gronewold, Malte, Raap, Mieke, Lehmann, Ulrich, Gluz, Oleg, Nitz, Ulrike, Kuemmel, Sherko ORCID: 0000-0001-9355-494X, Zu Eulenburg, Christine, Braun, Michael, Aktas, Bahriye, Grischke, Eva-Maria, Schumacher, Claudia, Luedtke-Heckenkamp, Kerstin, Kates, Ronald, Wuerstlein, Rachel, Graeser, Monika, Harbeck, Nadia, Christgen, Matthias and Kreipe, Hans
(2021).
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.
Cancer Med., 10 (23).
S. 8581 - 8595.
HOBOKEN:
WILEY.
ISSN 2045-7634